Here, we found that mutated GLUD2 decreased EAAT1 and EAAT2 expression and reduced glutamate uptake in the SN of MPTP-treated mice and the MPP+-treated glioma cell line U251. This evidence concerns the gene SLC1A3 and central nervous system cancer.